Biodistribution of Methotrexate in Lung Tumor
Corresponding Organization : RCSI & UCD Malaysia Campus
Other organizations : Mahsa University, INTI International University, AIMST University
Variable analysis
- Type of treatment received (NF, NFM, or Marketed MTX powder for injection)
- Amount of methotrexate (MTX) present in the lungs, spleens, kidneys, and hearts of the mice
- Mouse strain (C57BL/6)
- Tumor cell line (A549)
- Number of tumor cells injected (5 × 10^6 cells)
- Time for tumor development (30 days)
- Dose of PI administered (4 mg/kg)
- Time between PI administration and organ extraction (24 h)
- Analytical method (HPLC with Disodium phosphate buffer: Acetonitrile ratio of 89:11 on an Agilent 1260 Infinity Capillary LC system with a Phenomenex RP18 column)
- No positive or negative controls were explicitly mentioned in the provided information.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!